期刊文献+

刘晓鹰教授运用三豆饮治疗小儿本气自病发热经验 被引量:4

Professor LIU Xiaoying's experience in the treatment of pediatric fever due to underdevelopment of visceral qi by Sandouyin (三豆饮)
原文传递
导出
摘要 分别从病因病机、治疗机制、辨证要点和治疗中的注意事项等方面介绍了刘晓鹰教授运用三豆饮治疗小儿本气自病发热的经验,刘教授认为三豆饮组方平和,且药物便宜易得,小儿服食依从性高,临床疗效显著。附典型案例1则,以资验证。 To introduce professor LIU Xiaoying ’s experience in the treatment of pediatric fever due to underdevelopment of visceral qi by Sandouyin( 三豆饮),this paper elaborates from the aspects of etiology and pathogenesis,the therapeutic mechanism,key points of syndrome differentiation and precautions in treatment. She deems that the formula of Sandouyin is mild,with low price and easy obtainment. Its clinical curative is significant due to high compliance.One typical case is attached for verification.
作者 龙军颖 刘晓鹰 LONG Junying;LIU Xiaoying(Clinical College of TCM,Hubei University of Chinese Medicine,Wuhan,Hubei,430060,China;不详)
出处 《中医儿科杂志》 2019年第1期18-20,共3页 Journal of Pediatrics of Traditional Chinese Medicine
基金 国家中医药管理局全国名老中医药专家传承工作室建设项目(国中医药人教发[2010]59号)
关键词 小儿发热 三豆饮 本气自病 临床经验 刘晓鹰 pediatric fever Sandouyin(三豆饮) disease due to underdevelopment of visceral qi clinical experience LIU Xiaoying
  • 相关文献

参考文献2

二级参考文献13

  • 1雷波.合理选用小儿退热药[J].健康博览,2006(4):19-20. 被引量:2
  • 2兰玲.解热镇痛药不良反应山西省6年共报告3 300余例[N].山西晚报,2011-01-07-(4).
  • 3张军.儿童感冒发病高峰提前[N].北京日报,2009-10-28-(6).
  • 4FDA.Best Pharmaceuticals for Children Act[EB/OL].http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugand-CosmeticActFDCAct/default.htm.
  • 5FDA.Pediatric Research Equity Act[EB/OL].http://www.fda.gov/AboutFDA/WhatWeDo/History/Milestones/default.htm.
  • 6EMEA.Paediatric investigation plans[EB/OL].http://www.ema.europa.eu/ema/index.jsp curl=pages/regulation/document_listing/document_listing_000293.jsp&mid=WC0b01ac0580025b91&jsenabled=true.
  • 7FDA.Recall:Children's and Infants'Tylenol Oral SuspensionProducts[EB/OL].http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm184092.htm.
  • 8FDA.Additions to the List of Drug Products That Have BeenWithdrawn or Removed From the Market for Reasons of Safety orEffectiveness.Federal Register[EB/OL].[2000-01-04]http://www.fda.gov/ohrms/dockets/98fr/100898b.txt.2000.1.4.
  • 9WHO.Consolidated List of Products-Pharmceuticals[EB/OL].http://www.un.org/esa/coordination/CL12.pdf.
  • 10刘蕾,陈勇,白洁.儿童退热药物及合理选择[J].中国社区医师(医学专业),2010,12(30):25-26. 被引量:7

共引文献50

同被引文献40

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部